Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genizon BioSciences and Neuropsychiatrie, Decouverte & Innovation have agreed to collaborate to enhance and potentially add to discoveries made by Genizon in a genome-wide association study of schizophrenia.
Subscribe to our email newsletter
Genizon’s study identified multiple genes associated with the disease using DNA samples from patients from the Quebec founder population.
Michel Maziade, professor of psychiatry at the University of Laval, said: “Schizophrenia is a truly devastating disease for both those afflicted and their families. We expect the results of these studies to lead to a new generation of safer and more effective treatments tailored to individual schizophrenia patients. We are thrilled to be collaborating with Genizon to achieve this goal.”